Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

NUBPL Activators

The functional mechanisms by which NUBPL activators exert their influence are diverse and rooted in the modulation of intracellular signal transduction pathways. Compounds that elevate intracellular cyclic AMP (cAMP) levels do so by either direct stimulation of adenylate cyclase or inhibition of phosphodiesterases, leading to enhanced activation of protein kinase A (PKA). PKA then phosphorylates various substrates, including NUBPL, thus promoting its functional activity. Similarly, agents that stimulate protein kinase C (PKC) also contribute to the phosphorylation cascade, culminating in the activation of NUBPL. Moreover, modulation of phosphatase activity results in a sustained phosphorylated state of proteins, which in the case of NUBPL, translates to increased activity due to inhibited dephosphorylation.

Additional layers of regulation are apparent through the impact of small molecules on metal ion homeostasis and acetylation status of proteins. The presence of metal ions such as zinc can stabilize protein conformations, thereby potentially enhancing the activity of metalloproteins like NUBPL. Moreover, compounds that influence the activity of sirtuins, a class of deacetylases, may enhance NUBPL activity by deacetylating specific lysine residues, leading to its functional activation. Other small molecules exert their effect by modulating broader signaling pathways, which can result in the upregulation and activation of NUBPL, thus integrating NUBPL activity into the wider network of cellular signaling and ensuring its role in the cellular processes it is involved in is sustained and enhanced.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that stimulates adenylate cyclase activity, raising intracellular cAMP and subsequently activating NUBPL through phosphorylation.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor that prevents cAMP degradation, thereby sustaining NUBPL activation via phosphorylation.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Cell-permeable cAMP analog that activates PKA, which then may phosphorylate and activate NUBPL.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C which can phosphorylate NUBPL, leading to its activation.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation and activation of NUBPL.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Stabilizes protein structure and function, potentially enhancing the activity of metalloproteins like NUBPL.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates sirtuins which may deacetylate lysine residues on NUBPL, enhancing its activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Phosphodiesterase-4 inhibitor, increasing cAMP levels and potentially leading to NUBPL activation through phosphorylation.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Modulates signaling pathways such as NF-kB, which may result in upregulation and activation of NUBPL.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

Activates AMPK, which can lead to downstream phosphorylation and activation of NUBPL.